Literature DB >> 16189164

Pseudomyxoma peritonei: unusual origin from an ovarian mature cystic teratoma.

N Pranesh1, L P Menasce, M S Wilson, S T O'Dwyer.   

Abstract

Pseudomyxoma peritonei (PMP) is classified into pathologically and prognostically distinct categories, such as disseminated peritoneal adenomucinosis (DPAM) and peritoneal mucinous carcinomatosis. There is overwhelming evidence that DPAM arises from a mucinous adenoma of the appendix. The one exception to this is the presentation of a mature ovarian cystic teratoma as PMP where the appendix is normal. This report describes such a case and discusses the presentation, histopathology, and treatment options.

Entities:  

Mesh：

Year:  2005        PMID： 16189164      PMCID： PMC1770748          DOI： 10.1136/jcp.2004.025148

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


  12 in total

1.  Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.

Authors:  P H Sugarbaker
Journal:  Tumori       Date:  2001 Jul-Aug       Impact factor: 2.098

2.  Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis.

Authors:  B M Ronnett; H Yan; R J Kurman; B M Shmookler; L Wu; P H Sugarbaker
Journal:  Cancer       Date:  2001-07-01       Impact factor: 6.860

3.  Pseudomyxoma peritonei. New concepts in management with a report of seventeen patients.

Authors:  R T Long; J S Spratt; E Dowling
Journal:  Am J Surg       Date:  1969-02       Impact factor: 2.565

4.  Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women.

Authors:  C Szych; A Staebler; D C Connolly; R Wu; K R Cho; B M Ronnett
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

5.  Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'.

Authors:  K R Lee; R E Scully
Journal:  Am J Surg Pathol       Date:  2000-11       Impact factor: 6.394

6.  Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.

Authors:  Jerome T O'Connell; James S Tomlinson; Alice A Roberts; Kathryn F McGonigle; Sanford H Barsky
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.

Authors:  R A Prayson; W R Hart; R E Petras
Journal:  Am J Surg Pathol       Date:  1994-06       Impact factor: 6.394

8.  Mucinous cystadenoma and cystadenocarcinoma of the vermiform appendix with particular reference to mucocele and pseudomyxoma peritonei.

Authors:  N M Gibbs
Journal:  J Clin Pathol       Date:  1973-06       Impact factor: 3.411

9.  Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".

Authors:  B M Ronnett; C M Zahn; R J Kurman; M E Kass; P H Sugarbaker; B M Shmookler
Journal:  Am J Surg Pathol       Date:  1995-12       Impact factor: 6.394

10.  Cytokeratins 7 and 20, Dpc4, and MUC5AC in the distinction of metastatic mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas.

Authors:  Hongxiu Ji; Christina Isacson; Jeffrey D Seidman; Robert J Kurman; Brigitte M Ronnett
Journal:  Int J Gynecol Pathol       Date:  2002-10       Impact factor: 2.762
View more
  7 in total

1.  A proposal for changing nomenclature from pseudomyxoma peritonei (PMP) to abdomino-peritoneal mucinous carcinoma (APM) based on its long journey and experience from tertiary oncology center in India.

Authors:  M D Ray; Manish Kumar Gaur; Chandan Kumar; S V S Deo
Journal:  World J Surg Oncol       Date:  2022-06-01       Impact factor: 3.253

Review 2.  History of pseudomyxoma peritonei from its origin to the first decades of the twenty-first century.

Authors:  Francisco J Morera-Ocon; Clara Navarro-Campoy
Journal:  World J Gastrointest Surg       Date:  2019-09-27

3.  [Pseudomyxoma peritonei (PMP) secondary to mucinous carcinoma of the ovary: a case study].

Authors:  Mohamed Said Belhamidi; Youssef Zorkani; Hicham Krimou; Abdessamad Kaoukabi; Mohamed Menfaa; Fouad Sakit; Karim Choho
Journal:  Pan Afr Med J       Date:  2019-08-02

4.  A case of Pseudomyxoma Peritonei of an unexpected origin.

Authors:  Marie Csanyi-Bastien; France Blanchard; Aude Lamy; Jean-Christophe Sabourin
Journal:  Diagn Pathol       Date:  2021-12-20       Impact factor: 2.644

5.  Genetic diagnosis of pseudomyxoma peritonei originating from mucinous borderline tumor inside an ovarian teratoma.

Authors:  Ayumi Taguchi; Hirofumi Rokutan; Katsutoshi Oda; Michihiro Tanikawa; Saki Tanimoto; Kenbun Sone; Mayuyo Mori; Tetsushi Tsuruga; Shinji Kohsaka; Kenji Tatsuno; Aya Shinozaki-Ushiku; Kiyoshi Miyagawa; Hiroyuki Mano; Hiroyuki Aburatani; Tetsuo Ushiku; Yutaka Osuga
Journal:  BMC Med Genomics       Date:  2022-03-07       Impact factor: 3.063

6.  Pseudomyxoma peritonei presenting as inguinal hernia.

Authors:  Patrick Campbell; Suzanne Dawson; Jaweed Wali; Brian Kenny; Michael C R Whiteside
Journal:  Ulster Med J       Date:  2009-09

7.  A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.

Authors:  A L Farquharson; N Pranesh; G Witham; R Swindell; M B Taylor; A G Renehan; S Rout; M S Wilson; S T O'Dwyer; M P Saunders
Journal:  Br J Cancer       Date:  2008-08-19       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.